Immuno

Discussion in 'Bristol-Myers Squibb' started by Anonymous, Apr 15, 2014 at 6:37 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    So whats the deal with this division?
     

  2. Anonymous

    Anonymous Guest

    Wheels ready to come off. Will be ugly.
     
  3. Anonymous

    Anonymous Guest

    Team dynamics in most "pods" are tough. Older reps hate that more reps were added to the mix. Most of the new hires don't even have oncology experience. Even the institutional folks. Going to be an interesting launch, especially since Merck will have a first to market advantage.